| Literature DB >> 32127864 |
Shehab M Abd El-Kader1, Osama H Al-Jiffri2.
Abstract
BACKGROUND: Although post-menopausal obesity is an important public national health problem in Saudi Arabia, to date no study has evaluated the effects of weight reduction on biochemical & clinical parameters and quality of Life for obese Saudi post-menopausal women.Entities:
Keywords: Aerobic exercise; inflammatory cytokine; menopause; obesity; quality of life; resisted exercises
Mesh:
Substances:
Year: 2019 PMID: 32127864 PMCID: PMC7040316 DOI: 10.4314/ahs.v19i4.10
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Figure (1)Subjects screening and recruitment CONSORT diagram.
Baseline characteristics of study participants
| Characteristic | Group (A) | Group (B) | Significance |
| 56.42 ± 4.81 | 54.97 ± 5.63 | P>0.05 | |
| 34.28 ± 3.74 | 33.52 ± 3.68 | P>0.05 | |
| 136.51 ± 11.46 | 135.14 ±13.12 | P>0.05 | |
| 82.33 ± 6.27 | 80.81 ± 7.52 | P>0.05 | |
| 4.51 ± 0.64 | 4.35 ± 0.53 | P>0.05 | |
| 40.16 ± 7.23 | 38.62 ± 6.11 | P>0.05 | |
| 28.45 ± 6.18 | 27.71 ± 5.39 | P>0.05 |
BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.
Mean value and significance of TNF-α, IL-2, IL-4, IL-6 and CRP of group (A) before and at the end of the study
| Mean +SD | T-value | Significance | ||
| Before | After | |||
| 6.36 ± 1.74 | 4.38 ± 1.86 | 7.11 | P<0.05 | |
| 8.23 ± 2.31 | 4.75 ± 1.97 | 6.58 | P<0.05 | |
| 5.72 ± 1.44 | 3.46 ± 1.23 | 6.25 | P<0.05 | |
| 7.85 ± 2.13 | 4.55 ± 1.81 | 6.22 | P<0.05 | |
| 14.93 ± 3.82 | 8.31 ± 2.75 | 8.43 | P<0.05 | |
TNF-α: tumor necrosis factor – alpha; IL-2: Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; CRP: C-reactive protein
indicates a significant difference between the two groups, P < 0.05.
Mean value and significance of SF-36 subscale scores of group (B) before and at the end of the study
| SF-36 subscale | Mean +SD | T-value | Significance | |
| Before | After | |||
| SF-36: Health | 2.61 ± 0.92 | 2.11 ± 0.84 | 3.19 | P<0.05 |
| SF-36: Physica | 73.27 ± 8.51 | 77.68 ± 8.96 | 3.23 | P<0.05 |
| SF-36: Role | 80.21 ± 10.39 | 84.34 ± 10.75 | 3.42 | P<0.05 |
| SF-36: Bodily pain | 73.92 ± 7.48 | 70.74 ± 7.23 | 3.22 | P<0.05 |
| SF-36: General | 72.15 ± 9.87 | 75.22 ± 10.12 | 3.15 | P<0.05 |
| SF-36: Vitality | 57.81 ± 6.42 | 62.13 ± 6.76 | 3.41 | P<0.05 |
| SF-36: Social | 86.24 ± 11.26 | 89.57 ± 11.87 | 3.27 | P<0.05 |
| SF-36: Role | 90.83 ± 14.91 | 87.14 ± 13.22 | 3.31 | P<0.05 |
| SF-36: Mental | 84.16 ± 10.38 | 81.25± 10.18 | 3.45 | P<0.05 |
indicates a significant difference between the two groups; P < 0.05.
Mean value and significance of TNF- α, IL-6, IL-8 and CRP of group (A) and group (B) at the end of the study
| Mean +SD | T-value | Significance | ||
| Group (A) | Group (B) | |||
| 4.38 ± 1.86 | 5.13 ± 1.78 | 3.41 | P<0.05 | |
| 4.75 ± 1.97 | 6.74 ± 2.21 | 3.53 | P<0.05 | |
| 3.46 ± 1.23 | 4.37 ± 1.54 | 3.68 | P<0.05 | |
| 4.55 ± 1.81 | 6.14 ± 2.25 | 3.47 | P<0.05 | |
| 8.31 ± 2.75 | 11.82 ± 3.27 | 4.15 | P<0.05 | |
TNF- α: tumor necrosis factor – alpha; IL-2: Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; CRP: C-reactive protein
indicates a significant difference between the two groups, P < 0.05.
Mean value and significance of SF-36 subscale scores of group (A) and group (B) at the end of the study
| SF-36 subscale | Mean +SD | T-value | Significance | |
| Group (A) | Group (B) | |||
| SF-36: Health | 1.69 ± 0.61 | 2.11 ± 0.84 | 3.27 | P<0.05 |
| SF-36: Physical | 80.32 ± 10.12 | 77.68 ± 8.96 | 3.46 | P<0.05 |
| SF-36: Role | 87.13 ± 12.37 | 84.34 ± 10.75 | 3.49 | P<0.05 |
| SF-36: Bodily | 69.85 ± 6.25 | 70.74 ± 7.23 | 3.35 | P<0.05 |
| SF-36: General | 77.38 ± 10.19 | 75.22 ± 10.12 | 3.18 | P<0.05 |
| SF-36: Vitality | 66.97 ± 7.81 | 62.13 ± 6.76 | 3.52 | P<0.05 |
| SF-36: Social | 92.26 ± 13.31 | 89.57 ± 11.87 | 3.32 | P<0.05 |
| SF-36: Role | 84.51 ± 14.13 | 87.14 ± 13.22 | 3.61 | P<0.05 |
| SF-36: Mental | 78.24+ 8.97 | 81.25± 10.18 | 3.54 | P<0.05 |
indicates a significant difference between the two groups; P < 0.05.
Mean value and significance of SF-36 subscale scores of group (A) before and at the end of the study
| SF-36 subscale | Mean ± SD | T-value | Significance | |
| Before | After | |||
| SF-36: Health | 2.75 ± 0.83 | 1.69 ± 0.61 | 5.34 | P<0.05 |
| SF-36: Physical | 72.18 ± 9.43 | 80.32 ± 10.12 | 6.76 | P<0.05 |
| SF-36: Role | 78.96 ± 10.15 | 87.13 ± 12.37 | 6.81 | P<0.05 |
| SF-36: Bodily pain | 75.11 ± 7.63 | 69.85 ± 6.25 | 6.52 | P<0.05 |
| SF-36: General | 71.16± 9.44 | 77.38 ± 10.19 | 7.35 | P<0.05 |
| SF-36: Vitality | 57.27 ± 6.32 | 66.97 ± 7.81 | 6.41 | P<0.05 |
| SF-36: Social | 85.18 ± 11.17 | 92.26 ± 13.31 | 8.15 | P<0.05 |
| SF-36: Role | 92.42 ± 15.26 | 84.51 ± 14.13 | 7.86 | P<0.05 |
| SF-36: Mental | 84.71 ± 10.14 | 78.24+ 8.97 | 6.91 | P<0.05 |
indicates a significant difference between the two groups; P < 0.05.
Mean value and significance of TNF- α, IL-6, IL-8 and CRP of group (B) before and after treatment
| Mean +SD | T-value | Significance | ||
| Before | After | |||
| 5.93 ± 1.82 | 5.13 ± 1.78 | 3.61 | P<0.05 | |
| 8.15 ± 2.49 | 6.74 ± 2.21 | 3.87 | P<0.05 | |
| 5.63 ± 1.61 | 4.37 ± 1.54 | 3.52 | P<0.05 | |
| 7.65 ± 2.38 | 6.14 ± 2.25 | 3.68 | P<0.05 | |
| 14.67 ± 3.91 | 11.82 ± 3.27 | 4.36 | P<0.05 | |
TNF- α: tumor necrosis factor – alpha; IL-2: Interleukin-2; IL-4: Interleukin-4; IL-6: Interleukin-6; CRP: C-reactive protein
indicates a significant difference between the two groups, P < 0.05.